| Product Code: ETC13210161 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Breast Cancer Liquid Biopsy Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Breast Cancer Liquid Biopsy Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Breast Cancer Liquid Biopsy Market Revenues & Volume, 2021 & 2031F |
3.3 North America Breast Cancer Liquid Biopsy Market - Industry Life Cycle |
3.4 North America Breast Cancer Liquid Biopsy Market - Porter's Five Forces |
3.5 North America Breast Cancer Liquid Biopsy Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Breast Cancer Liquid Biopsy Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 North America Breast Cancer Liquid Biopsy Market Revenues & Volume Share, By Circulating Biomarkers, 2021 & 2031F |
3.8 North America Breast Cancer Liquid Biopsy Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 North America Breast Cancer Liquid Biopsy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Breast Cancer Liquid Biopsy Market Trends |
6 North America Breast Cancer Liquid Biopsy Market, 2021 - 2031 |
6.1 North America Breast Cancer Liquid Biopsy Market, Revenues & Volume, By Product, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Breast Cancer Liquid Biopsy Market, Revenues & Volume, By Consumables, 2021 - 2031 |
6.1.3 North America Breast Cancer Liquid Biopsy Market, Revenues & Volume, By Kits, 2021 - 2031 |
6.2 North America Breast Cancer Liquid Biopsy Market, Revenues & Volume, By Circulating Biomarkers, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Breast Cancer Liquid Biopsy Market, Revenues & Volume, By Extracellular Vesicles (EVs), 2021 - 2031 |
6.2.3 North America Breast Cancer Liquid Biopsy Market, Revenues & Volume, By Cell-free DNA (cfDNA), 2021 - 2031 |
6.2.4 North America Breast Cancer Liquid Biopsy Market, Revenues & Volume, By ctRNA, 2021 - 2031 |
6.2.5 North America Breast Cancer Liquid Biopsy Market, Revenues & Volume, By Circulating Tumor Cells (CTCs), 2021 - 2031 |
6.2.6 North America Breast Cancer Liquid Biopsy Market, Revenues & Volume, By cfRNA, 2021 - 2031 |
6.2.7 North America Breast Cancer Liquid Biopsy Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 North America Breast Cancer Liquid Biopsy Market, Revenues & Volume, By End Users, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Breast Cancer Liquid Biopsy Market, Revenues & Volume, By Laboratories, 2021 - 2031 |
6.3.3 North America Breast Cancer Liquid Biopsy Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.4 North America Breast Cancer Liquid Biopsy Market, Revenues & Volume, By Physician Laboratories, 2021 - 2031 |
6.3.5 North America Breast Cancer Liquid Biopsy Market, Revenues & Volume, By Reference Laboratories, 2021 - 2031 |
6.3.6 North America Breast Cancer Liquid Biopsy Market, Revenues & Volume, By Public Health Laboratories, 2021 - 2031 |
6.3.7 North America Breast Cancer Liquid Biopsy Market, Revenues & Volume, By Research Institutes, 2021 - 2031 |
6.3.8 North America Breast Cancer Liquid Biopsy Market, Revenues & Volume, By Small Molecular Laboratories, 2021 - 2031 |
6.3.9 North America Breast Cancer Liquid Biopsy Market, Revenues & Volume, By Pathology Laboratories, 2021 - 2031 |
7 North America Breast Cancer Liquid Biopsy Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Breast Cancer Liquid Biopsy Market, Revenues & Volume, By Product, 2021 - 2031 |
7.2.1 United States (US) Breast Cancer Liquid Biopsy Market, Revenues & Volume, By Product, 2021 - 2031 |
7.2.2 Canada Breast Cancer Liquid Biopsy Market, Revenues & Volume, By Product, 2021 - 2031 |
7.2.3 Rest of North America Breast Cancer Liquid Biopsy Market, Revenues & Volume, By Product, 2021 - 2031 |
7.3 North America Breast Cancer Liquid Biopsy Market Revenues & Volume Share, By Circulating Biomarkers, 2021 & 2031F |
7.3.1 United States (US) Breast Cancer Liquid Biopsy Market, Revenues & Volume, By Circulating Biomarkers, 2021 - 2031 |
7.3.2 Canada Breast Cancer Liquid Biopsy Market, Revenues & Volume, By Circulating Biomarkers, 2021 - 2031 |
7.3.3 Rest of North America Breast Cancer Liquid Biopsy Market, Revenues & Volume, By Circulating Biomarkers, 2021 - 2031 |
7.4 North America Breast Cancer Liquid Biopsy Market, Revenues & Volume, By End Users, 2021 - 2031 |
7.4.1 United States (US) Breast Cancer Liquid Biopsy Market, Revenues & Volume, By End Users, 2021 - 2031 |
7.4.2 Canada Breast Cancer Liquid Biopsy Market, Revenues & Volume, By End Users, 2021 - 2031 |
7.4.3 Rest of North America Breast Cancer Liquid Biopsy Market, Revenues & Volume, By End Users, 2021 - 2031 |
8 North America Breast Cancer Liquid Biopsy Market Key Performance Indicators |
9 North America Breast Cancer Liquid Biopsy Market - Export/Import By Countries Assessment |
10 North America Breast Cancer Liquid Biopsy Market - Opportunity Assessment |
10.1 North America Breast Cancer Liquid Biopsy Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Breast Cancer Liquid Biopsy Market Opportunity Assessment, By Product, 2021 & 2031F |
10.3 North America Breast Cancer Liquid Biopsy Market Opportunity Assessment, By Circulating Biomarkers, 2021 & 2031F |
10.4 North America Breast Cancer Liquid Biopsy Market Opportunity Assessment, By End Users, 2021 & 2031F |
11 North America Breast Cancer Liquid Biopsy Market - Competitive Landscape |
11.1 North America Breast Cancer Liquid Biopsy Market Revenue Share, By Companies, 2022 |
11.2 North America Breast Cancer Liquid Biopsy Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here